Search

Your search keyword '"Dou, Xiaoguang"' showing total 202 results

Search Constraints

Start Over You searched for: Author "Dou, Xiaoguang" Remove constraint Author: "Dou, Xiaoguang"
202 results on '"Dou, Xiaoguang"'

Search Results

1. Role of Early On-Treatment Serum HBV RNA Declines in Predicting Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis B

2. Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures

4. WED-412 Functional cure and prediction analysis of pegylated interferon alpha-2b in HBeAg negative chronic hepatitis B patients with normal ALT (Ice-breaking Project in China): an interim analysis update

5. LBP-037 Role of early on-treatment serum hepatitis B virus RNA declines in the prediction of hepatocellular carcinoma risk in patients with chronic hepatitis B

10. Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy

14. Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis

15. Novel, high accuracy prediction models of hepatocellular carcinoma based on longitudinal data and cell-free DNA signatures

16. High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy

17. Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg‐positive chronic hepatitis B

18. OS-033 - Novel, high accuracy prediction models of hepatocellular carcinoma based on longitudinal data and cell-free DNA signatures

19. Association between nonalcoholic fatty liver disease status changes and antiviral efficacy in chronic hepatitis B

20. Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B

21. Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)

22. Global multi-stakeholder endorsement of the MAFLD definition

23. Global multi-stakeholder endorsement of the MAFLD definition

26. Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

28. The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease

29. Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients

33. The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: A randomized, controlled study

34. Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection

36. SAT-193 - Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis

37. Clinical significance of serum HBV RNA measurement in chronic hepatitis B patients

38. Antiviral therapeutic strategies for chronic hepatitis B patients with a normal alanine aminotransferase level

40. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

41. Relationship between Hepatitis B virus infection and platelet production and dysfunction.

42. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

45. Combination of NA, PEG-IFN alpha-2b and GM-CSF enhanced hbsab production in NA experienced CHB patients (the anchor a study): an interim analysis

47. Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy

49. Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B

50. Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy.

Catalog

Books, media, physical & digital resources